Abstract
The feasibility of using alkaline phosphatase (ALP) as a generic label in a homogeneous type assay is examined. In the proposed ALP-based biotin-avidin mediated assay, the activity of the ALP-biotin conjugate is inhibited in the presence of the avidin-riboflavin conjugate, and the observed inhibition is reversed in an amount proportional to the concentration of riboflavin binding protein (RBP) added. The ALP activity of the mixture is re-inhibited upon additions of free analyte riboflavin, to an extent proportional to the concentration of riboflavin added to the assay mixture. An avidin-riboflavin conjugate with a desired inhibitory effect is prepared by protecting the binding-site of avidin with 2-iminobiotin during the conjugation reaction at pH 6.5. The catalytic activity of ALP, conjugated with biotin, is inhibited to a significant degree (up to 86%) by the binding of the avidin-riboflavin conjugate, and is fully recovered upon additions of RBP.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
